SANTA CLARA, Calif., June 16, 2026—ValGenesis Inc., the market leader in enterprise digital validation, announced that Ulrich Medical has selected ValGenesis iVal™ to modernize computer system validation (CSV) processes in support of its broader digital transformation and upcoming SAP implementation.
The Germany-based medical device company will replace manual validation processes with a digital approach to manage increased CSV activity associated with the SAP rollout. The initial deployment will begin at Ulrich Medical’s headquarters, with plans for global expansion.
Part of the AI-enabled ValGenesis Smart GxP™ platform, iVal centralizes validation planning, test authoring, and execution to enable more efficient and scalable CSV processes. With offline execution, automated deviation management, integrated risk assessments, and change impact analysis, the platform helps organizations streamline validation workflows, improve traceability, and maintain regulatory compliance across global operations.
“Modernizing CSV was a prerequisite for our SAP rollout,” said Matthias Novotny, Head of Process and Lean Management at Ulrich Medical. “ValGenesis gives us the efficiency we need to manage a significantly higher validation workload with greater accuracy and consistency, allowing us to keep pace with evolving global regulations without overstretching our team.”
“As medical device companies expand digital transformation initiatives and enterprise system deployments, they face growing pressure to manage validation activities more efficiently while maintaining compliance,” said Anna Beamish, vice president of global sales at ValGenesis. “By implementing iVal, Ulrich Medical is moving toward a digital validation approach that can scale with its global operations and long-term growth."
About Ulrich Medical
Ulrich Medical develops, manufactures, and markets innovative medical technology. Founded in 1912, the company celebrates its 114th anniversary this year. Healthcare professionals worldwide rely on its decades of expertise. With product divisions in spinal implants and contrast media injectors for CT and MRI, Ulrich Medical offers a broad portfolio of advanced solutions. The company is among the few in the industry to retain both development and production in Germany, supported by state-of-the-art manufacturing technologies. As an owner-operated business, it remains independent and continues to deliver steady, sustainable growth. For more information, visit ulrichmedical.com
About ValGenesis Inc.
ValGenesis, Inc. is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information, visit valgenesis.com
Media Contacts:
Althea D'Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 althea.dsylva@valgenesis.com
Matthias Novotny, Ulrich Medical, +49 731 9654 1388, M.Novotny@ulrichmedical.com